PURPOSE: To examine the impact of cancer on work and education in a sample of adolescent and young adult (AYA) patients with cancer. PATIENTS AND METHODS: By using the Adolescent and Young Adult Health Outcomes and Patient Experience Study (AYA HOPE)-a cohort of 463 recently diagnosed patients age 15 to 39 years with germ cell cancer, Hodgkin's lymphoma, non-Hodgkin's lymphoma, sarcoma, and acute lymphocytic leukemia from participating Surveillance, Epidemiology, and End Results (SEER) cancer registries-we evaluated factors associated with return to work/school after cancer diagnosis, a belief that cancer had a negative impact on plans for work/school, and reported problems with work/school after diagnosis by using descriptive statistics, χ(2) tests, and multivariate logistic regression. RESULTS: More than 72% (282 of 388) of patients working or in school full-time before diagnosis had returned to full-time work or school 15 to 35 months postdiagnosis compared with 34% (14 of 41) of previously part-time workers/students, 7% (one of 14) of homemakers, and 25% (five of 20) of unemployed/disabled patients (P < .001). Among full-time workers/students before diagnosis, patients who were uninsured (odds ratio [OR], 0.21; 95% CI, 0.07 to 0.67; no insurance v employer-/school-sponsored insurance) or quit working directly after diagnosis (OR, 0.15; 95% CI, 0.06 to 0.37; quit v no change) were least likely to return. Very intensive cancer treatment and quitting work/school were associated with a belief that cancer negatively influenced plans for work/school. Finally, more than 50% of full-time workers/students reported problems with work/studies after diagnosis. CONCLUSION: Although most AYA patients with cancer return to work after cancer, treatment intensity, not having insurance, and quitting work/school directly after diagnosis can influence work/educational outcomes. Future research should investigate underlying causes for these differences and best practices for effective transition of these cancer survivors to the workplace/school after treatment.
PURPOSE: To examine the impact of cancer on work and education in a sample of adolescent and young adult (AYA) patients with cancer. PATIENTS AND METHODS: By using the Adolescent and Young Adult Health Outcomes and Patient Experience Study (AYA HOPE)-a cohort of 463 recently diagnosed patients age 15 to 39 years with germ cell cancer, Hodgkin's lymphoma, non-Hodgkin's lymphoma, sarcoma, and acute lymphocytic leukemia from participating Surveillance, Epidemiology, and End Results (SEER) cancer registries-we evaluated factors associated with return to work/school after cancer diagnosis, a belief that cancer had a negative impact on plans for work/school, and reported problems with work/school after diagnosis by using descriptive statistics, χ(2) tests, and multivariate logistic regression. RESULTS: More than 72% (282 of 388) of patients working or in school full-time before diagnosis had returned to full-time work or school 15 to 35 months postdiagnosis compared with 34% (14 of 41) of previously part-time workers/students, 7% (one of 14) of homemakers, and 25% (five of 20) of unemployed/disabled patients (P < .001). Among full-time workers/students before diagnosis, patients who were uninsured (odds ratio [OR], 0.21; 95% CI, 0.07 to 0.67; no insurance v employer-/school-sponsored insurance) or quit working directly after diagnosis (OR, 0.15; 95% CI, 0.06 to 0.37; quit v no change) were least likely to return. Very intensive cancer treatment and quitting work/school were associated with a belief that cancer negatively influenced plans for work/school. Finally, more than 50% of full-time workers/students reported problems with work/studies after diagnosis. CONCLUSION: Although most AYA patients with cancer return to work after cancer, treatment intensity, not having insurance, and quitting work/school directly after diagnosis can influence work/educational outcomes. Future research should investigate underlying causes for these differences and best practices for effective transition of these cancer survivors to the workplace/school after treatment.
Authors: Nancy M Nachreiner; Rada K Dagher; Patricia M McGovern; Beth A Baker; Bruce H Alexander; Susan Goodwin Gerberich Journal: AAOHN J Date: 2007-07
Authors: Branlyn E Werba; Wendy Hobbie; Anne E Kazak; Richard F Ittenbach; Anne F Reilly; Anna T Meadows Journal: Pediatr Blood Cancer Date: 2007-06-15 Impact factor: 3.167
Authors: Jenny W Y Pang; Debra L Friedman; John A Whitton; Marilyn Stovall; Ann C Mertens; Leslie L Robison; Noel S Weiss Journal: Pediatr Blood Cancer Date: 2008-01 Impact factor: 3.838
Authors: Xiao-Cheng Wu; Pinki K Prasad; Ian Landry; Linda C Harlan; Helen M Parsons; Charles F Lynch; Ashley W Smith; Ann S Hamilton; Theresa H M Keegan Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-09-29 Impact factor: 4.254
Authors: Ashley Wilder Smith; Keith M Bellizzi; Theresa H M Keegan; Brad Zebrack; Vivien W Chen; Anne Victoria Neale; Ann S Hamilton; Margarett Shnorhavorian; Charles F Lynch Journal: J Clin Oncol Date: 2013-05-06 Impact factor: 44.544
Authors: Susan M Sawyer; Robyn McNeil; Maria McCarthy; Lisa Orme; Kate Thompson; Sarah Drew; David Dunt Journal: Support Care Cancer Date: 2017-03-06 Impact factor: 3.603
Authors: Sharyl J Nass; Lynda K Beaupin; Wendy Demark-Wahnefried; Karen Fasciano; Patricia A Ganz; Brandon Hayes-Lattin; Melissa M Hudson; Brenda Nevidjon; Kevin C Oeffinger; Ruth Rechis; Lisa C Richardson; Nita L Seibel; Ashley W Smith Journal: Oncologist Date: 2015-01-07
Authors: Lena Wettergren; Erin E Kent; Sandra A Mitchell; Brad Zebrack; Charles F Lynch; Mara B Rubenstein; Theresa H M Keegan; Xiao-Cheng Wu; Helen M Parsons; Ashley Wilder Smith Journal: Psychooncology Date: 2016-06-20 Impact factor: 3.894
Authors: Theresa H M Keegan; Li Tao; Mindy C DeRouen; Xiao-Cheng Wu; Pinki Prasad; Charles F Lynch; Margarett Shnorhavorian; Brad J Zebrack; Roland Chu; Linda C Harlan; Ashley W Smith; Helen M Parsons Journal: J Cancer Surviv Date: 2014-01-10 Impact factor: 4.442
Authors: Tyler G Ketterl; Karen L Syrjala; Jacqueline Casillas; Linda A Jacobs; Steven C Palmer; Mary S McCabe; Patricia A Ganz; Linda Overholser; Ann Partridge; Emily Jo Rajotte; Abby R Rosenberg; Betsy Risendal; Donald L Rosenstein; Kevin Scott Baker Journal: Cancer Date: 2019-02-01 Impact factor: 6.860